Wanbury Share Price
246.70+3.35 (+1.38%)
-11.83% past 1 Year
News
Wanbury receives EDQM and USFDA clearances for key API products
Equity
WANBURY
Wanbury gets USFDA comfort, explores South Korea API opportunities
Equity
WANBURY
Wanbury receives USFDA Form 483 with six Tanuku facility observations
Equity
WANBURY
Wanbury Tanuku unit receives 6 USFDA GMP observations, plans timely response
Equity
WANBURY
Wanbury releases major promoter pledge, secures lower sub-10% borrowing cost
Equity
WANBURY
Wanbury gains TGA approval enabling additional API shipments from Tanuku site
Equity
WANBURY
Wanbury expands global API footprint, clears Korea FDA audit at Patalganga plant
Equity
WANBURY
Wanbury reports higher Q4 EBITDA margin versus year ago
Equity
WANBURY
Wanbury Q4 FY earnings show higher net profit despite revenue decline
Equity
WANBURY
Wanbury Patalganga Site Passes Korea FDA Inspection Without Issues.
Equity
WANBURY
Wanbury Launches Coriminic CPM Drops and Coriminic NS Nasal Drops for Children Amid Cold Medicine Regulations.
Equity
WANBURY
Wanbury Secures Sertraline Form II Approval in Brazil, Holds 75% Market Share.
Equity
WANBURY
Wanbury Q3 FY26 Results: EBITDA Surges 92% YoY to Rs 26.70 Crores
Equity
WANBURY
Wanbury Q3 FY26 Net Profit Jumps to Rs 15.80 Crores, Revenue Rises to Rs 160 Crores YoY.
Equity
WANBURY
Wanbury Launches Anesthetic APIs at Tanuku Facility, Targets Rs 100 Crore Revenue by FY 2026-27.
Equity
WANBURY
Wanbury Limited Launches Four New Anesthetic APIs at Tanuku Facility Targeting Rs 100 Crore Revenue in FY 2026-27.
Equity
WANBURY
Wanbury Limited reports significant year-on-year growth in Q2 earnings and revenues for FY2025.
Equity
WANBURY
Wanbury announces successful implementation of SAP S/4HANA Private Cloud, marking digital transformation milestone
Equity
WANBURY
Wanbury: Q1 Cons Net Profit 13.50 Crores Rupees Vs 1.04 Crores (Yoy) || Q1 Revenue 160.00 Crores Rupees Vs 130.00 Crores (Yoy)
Equity
WANBURY
Wanbury: Company Introduces Iron Supplement 'Wanbury Cred' Aimed At Fighting Anemia With Enhanced Safety And Absorption. ??
Equity
WANBURY